Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elanco Animal Health IncELAN · Entity 3457 | SEE REMARKS | July 01, 2026 | July 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elanco Animal Health Inc
Report date July 01, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.09 · Expires 2036-07-01 | Direct | 25,620 |
Reported balance
After 2026-07-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 25,620 · Balance 25,620 F1: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 2, 2026 20:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 25,620 | $0.00 Strike: $24.09 | $0.00 |
DisclosureSEC source: 0001752439-26-000007 · form4-07022026_080741.xml · derivative · entry 1 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,620 Underlying: Common Stock · 25,620 shares Expires 2036-07-01 F1 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:11 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 3,433 | $24.88 | $85,413.04 |
DisclosureSEC source: 0001752439-26-000004 · form4-03052026_090345.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,264 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 19,350 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001752439-26-000002 · form4-03042026_120341.xml · derivative · entry 4 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,350 Underlying: Common Stock · 19,350 shares Expires 2036-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 9,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001752439-26-000002 · form4-03042026_120341.xml · nonDerivative · entry 3 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,697 F2 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 15,377 | $26.40 | $405,952.80 |
DisclosureSEC source: 0001752439-26-000002 · form4-03042026_120341.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,227 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 33,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001752439-26-000002 · form4-03042026_120341.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,604 F1 · balance_after: Includes 648 shares acquired on April 30, 2025, 518 shares acquired on July 31, 2025, 221 shares acquired on October 31, 2025, and 252 shares acquired on January 31, 2026 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan . Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:47 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 46,383 | $0.00 Strike: $11.31 | $0.00 |
DisclosureSEC source: 0001415889-25-007077 · form4-03052025_110337.xml · derivative · entry 2 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,383 Underlying: Common Stock · 46,383 shares Expires 2035-03-03 F2 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:47 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 22,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007077 · form4-03052025_110337.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,878 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:27 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 7,162 | $11.17 | $79,999.54 |
DisclosureSEC source: 0001415889-25-006617 · form4-03042025_100341.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,773 Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:17 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 17,968 | $11.24 | $201,960.32 |
DisclosureSEC source: 0001415889-25-005168 · form4-02212025_110204.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,935 Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 23:17 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 40,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-005168 · form4-02212025_110204.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,903 F1 · balance_after: Includes 454 shares acquired on April 30, 2024, 524 shares acquired on July 31, 2024, 464 shares acquired on October 31, 2024, and 568 shares acquired on January 31, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:26 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option(right to buy) · Derivative | 34,014 | $0.00 Strike: $16.03 | $0.00 |
DisclosureSEC source: 0001415889-24-006642 · form4-03052024_090314.xml · derivative · entry 3 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,014 Underlying: Common Stock · 34,014 shares Expires 2034-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:26 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 5,731 | $16.03 | $91,867.93 |
DisclosureSEC source: 0001415889-24-006642 · form4-03052024_090314.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,646 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:26 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 15,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006642 · form4-03052024_090314.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,377 F1 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 23:27 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 6,625 | $16.46 | $109,047.50 |
DisclosureSEC source: 0001415889-24-005977 · form4-02292024_110230.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,781 Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 23:27 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 14,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-005977 · form4-02292024_110230.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,406 F1 · balance_after: Includes 632 shares acquired on March 31, 2023, 591 shares acquired on June 30, 2023, 529 shares acquired on September 29, 2023 and 399 shares acquired on December 29, 2023, under Elanco Animal Health Inc.'s Employee Stock Purchase Plan . Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 02:07 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 1,009 | $11.01 | $11,109.09 |
DisclosureSEC source: 0001415889-23-004286 · form4-03042023_020351.xml · nonDerivative · entry 3 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,541 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. F4 · balance_after: Balance reflects 580 fewer shares due to an error in the number of shares previously reported as forfeited in a prior Form 4. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 23:51 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 12,419 | $11.01 | $136,733.19 |
DisclosureSEC source: 0001415889-23-004355 · form4-03062023_110331.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,693 Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 23:51 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 28,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004355 · form4-03062023_110331.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,112 Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:07 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 50,863 | $0.00 Strike: $11.26 | $0.00 |
DisclosureSEC source: 0001415889-23-004286 · form4-03042023_020351.xml · derivative · entry 4 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,863 Underlying: Common Stock · 50,863 shares Expires 2033-03-01 F5 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:07 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 22,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004286 · form4-03042023_020351.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,130 F3 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:07 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 2,482 | $11.26 | $27,947.32 |
DisclosureSEC source: 0001415889-23-004286 · form4-03042023_020351.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,860 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. F2 · balance_after: Includes 699 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan between September 30, 2022 and December 30, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 02:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 874 | $29.00 | $25,346.00 |
DisclosureSEC source: 0001415889-22-002471 · form4-03032022_060346.xml · nonDerivative · entry 3 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,643 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 02:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option(right to buy) · Derivative | 23,026 | $0.00 Strike: $28.94 | $0.00 |
DisclosureSEC source: 0001415889-22-002471 · form4-03032022_060346.xml · derivative · entry 4 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,026 Underlying: Common Stock · 23,026 shares Expires 2032-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 02:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 1,724 | $28.94 | $49,892.56 |
DisclosureSEC source: 0001415889-22-002471 · form4-03032022_060346.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,517 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 02:01 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 8,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002471 · form4-03032022_060346.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,241 F1 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:40 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 9,400 | $25.98 | $244,212.00 |
DisclosureSEC source: 0001179110-22-001598 · edgar.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,576 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:40 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 22,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001598 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,976 F1 · price: Vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 20:23 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 2,065 | $33.66 | $69,507.90 |
DisclosureSEC source: 0001179110-21-009596 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,378 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 23:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 573 | $32.34 | $18,530.82 |
DisclosureSEC source: 0000950138-21-000176 · edgar.xml · nonDerivative · entry 3 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,443 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 483 | $33.65 | $16,252.95 |
DisclosureSEC source: 0000950138-21-000176 · edgar.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,016 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 6,717 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-21-000176 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,499 F1 · price: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2021, one-third vesting on March 1, 2022, one-third vesting on March 1, 2023, and the remaining vesting on March 1, 2024. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:25 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 3,870 | $30.58 | $118,344.60 |
DisclosureSEC source: 0000950138-21-000145 · edgar.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,782 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:25 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 13,540 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-21-000145 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,652 F1 · price: Vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 22:06 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 5,354 | $30.67 | $164,207.18 |
DisclosureSEC source: 0000950138-21-000009 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,112 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:35 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 6,075 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000122 · edgar.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,466 F2 · price: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 2, 2020, one-third vesting on March 2, 2021, one-third vesting on March 2, 2022, and the remaining vesting on March 2, 2023. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 22:35 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 736 | $27.40 | $20,166.40 |
DisclosureSEC source: 0000950138-20-000122 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,391 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 22:02 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 4,090 | $30.98 | $126,708.20 |
DisclosureSEC source: 0000950138-20-000091 · edgar.xml · nonDerivative · entry 2 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,127 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 22:02 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 14,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000091 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,217 F1 · price: Vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:26 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 4,888 | $29.45 | $143,951.60 |
DisclosureSEC source: 0000950138-20-000004 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,909 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 22:06 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 34,228 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000148 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,797 F1 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 12, 2019, with 16,300 vesting on December 31, 2019 and 17,928 vesting on December 31, 2020. Awards issued in replacement of previously held awards with respect to shares of common stock of Eli Lilly & Company (Lilly), which were forfeited in connection with the completion of an exchange offer on March 11, 2019 by Lilly, in which Lilly disposed of all of Elanco's shares held by it. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 21:59 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 7,977 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950138-19-000133 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,569 F1 · price: On March 11, 2019, Eli Lilly and Company ("Lilly") announced the completion of its offer to exchange shares of Lilly common stock for all of the common stock of the Issuer owned by Lilly (the "Exchange Offer"). The Reporting Person tendered 13,000 shares of Lilly common stock in the Exchange Offer, which shares were subject to a proration factor of 13.5970839%. As a result, the Reporting Person received 7,977 shares of Issuer common stock in exchange for 1,768 shares of Lilly common stock accepted in the Exchange Offer, based on an exchange ratio of 4.5121 shares of Issuer common stock for each share of Lilly common stock accepted. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 22:53 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 5,113 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000113 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,592 F1 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2019, one-third vesting on March 1, 2020, one-third vesting on March 1, 2021, and the remaining vesting on March 1, 2022. Read SEC document |
| October 20, 2018 Filed Oct 23, 2018 23:13 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantNon-Qualified Stock Option (Right-to-Buy) · Derivative | 21,086 | Not disclosed Strike: $31.61 | Not disclosed |
DisclosureSEC source: 0000950138-18-000572 · edgar.xml · derivative · entry 2 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,086 Underlying: Elanco Animal Health Inc. Common Stock · 21,086 shares Expires 2028-10-20 F2 · price: Grant of stock option pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021. F2 · derivative.exercise_date: Grant of stock option pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021. Read SEC document |
| October 20, 2018 Filed Oct 23, 2018 23:13 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 6,979 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-18-000572 · edgar.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,479 F1 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 20:23 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 2,500 | $24.00 | $60,000.00 |
DisclosureSEC source: 0001140361-18-039160 · form4.xml · nonDerivative · entry 1 Kinard David S · CIK 0001752439 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.